Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Annals of Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/annonc/mdn526PMID 18647964
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Osteonecrosis of the jaw and bisphosphonates

  2010cited by this paper
• Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel.

  2008cited by this paper
• Decreases in pain at rest and movement-related pain during zoledronic acid treatment in patients with bone metastases due to breast or prostate cancer: a pilot study

  2007cited by this paper
• International Society of Geriatric Oncology (SIOG) clinical practice recommendations for the use of bisphosphonates in elderly patients.

  2007cited by this paper
• Critical review: updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients--May 2006.

  2007cited by this paper
• American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma.

  2007cited by this paper
• Systematic Review: Bisphosphonates and Osteonecrosis of the Jaws

  2006cited by this paper
• Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer.

  2006cited by this paper
• Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors.

  2006cited by this paper
• Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws.

  2006influential reference
• Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.

  2005cited by this paper
• Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.

  2005cited by this paper
• Osteonecrosis of the jaw and bisphosphonates.

  2005cited by this paper
• Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial.

  2005cited by this paper
• Expert panel recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaws.

  2005cited by this paper
• Special precautions

  2005cited by this paper
• Osteonecrosis of the jaw and bisphosphonates.

  2005cited by this paper
• Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper.

  2005cited by this paper
• Bisphosphonate‐associated osteonecrosis of mandibular and maxillary bone

  2005cited by this paper
• Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer.

  2004cited by this paper
• Mechanisms of bone metastasis.

  2004cited by this paper
• Mechanisms of bone metastasis.

  2004cited by this paper
• Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group.

  2003cited by this paper
• Long‐term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma

  2003cited by this paper
• Zoledronic acid delays the onset of skeletal‐related events and progression of skeletal disease in patients with advanced renal cell carcinoma

  2003cited by this paper
• Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic.

  2003cited by this paper
• Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases.

  2003cited by this paper
• American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma.

  2002cited by this paper
• Bisphosphonate therapy in multiple myeloma: past, present, future

  2002cited by this paper
• Metastatic bone disease: clinical features, pathophysiology and treatment strategies.

  2001cited by this paper
• The role of disodium pamidronate in the management of bone pain due to malignancy

  2001cited by this paper
• American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel.

  2000cited by this paper
• Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases

  2000cited by this paper
• The role of bisphosphonates in the treatment of painful metastatic bone disease: a review of phase III trials

  1998cited by this paper
• A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma

  1998cited by this paper
• Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogens.

  1997cited by this paper
• Skeletal complications of malignancy

  1997cited by this paper
• Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.

  1993cited by this paper

• Medication-related osteonecrosis of the jaw primary prevention: multidomain long-term intervention versus pre-bisphosphonate treatment standalone dental intervention. A retrospective multi-center comparative cohort study

  2026cites this paper
• Treatment of myeloma bone disease: When, how often, and for how long?

  2025cites this paper
• Knowledge and Attitudes of Oral Health Professionals to Different Dental Treatment Approaches in Bisphosphonate Therapy

  2025cites this paper
• Multicenter prospective study on the development of bisphosphonate-related osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates (complete translation)

  2025cites this paper
• Iatrogenic Head and Neck Necrosis of Bone and Soft Tissue in Cancer Patients

  2025cites this paper
• Long-Term Management of Breast Cancer Bone Metastases: Two Case Reports

  2025cites this paper
• Prevention of medication-related osteonecrosis of the jaws (MRONJ): updated recommendations for dental hygienists from the Italian consensus conference

  2025cites this paper
• Dental assessment pro forma for adult patients at risk of medication-related osteonecrosis of the jaw

  2025cites this paper
• How does medication-related osteonecrosis of the jaw (MRONJ) influence the health-related quality of life after surgery?

  2025cites this paper
• Italian position paper (SIPMO‐SICMF) on medication‐related osteonecrosis of the jaw (MRONJ)

  2024cites this paper
• A systematic review of dentists’ knowledge, perception, practice and confidence in managing patients with cancers

  2024cites this paper
• Impact of Bisphosphonate Therapy on Oral Health in Patients with Breast and Prostate Cancer and Bone Metastases: A Comprehensive Study

  2024cites this paper
• Infection may play an important role in the pathogenesis of alveolar osteonecrosis following facial herpes zoster: a case report and literature review

  2024influential citation
• How we manage medication-related osteonecrosis of the jaw

  2024cites this paper
• Potential role of comprehensive dental care in preventing medication related osteonecrosis of the jaw (MRONJ): a single centre study

  2024influential citation
• In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease

  2024cites this paper
• Complication avoidance, rehabilitation, pain therapy and palliative care for patients with metastatic spine tumors: WFNS spine committee recommendations

  2024cites this paper
• Стоматологическая помощь пациентам с медикаментозным остеонекрозом челюстей

  2023cites this paper
• The Dental Oncology Complication that Wouldn’t go Away

  2023influential citation
• Bisphosphonates and osteonecrosis of the jaws: Clinical and forensic aspects.

  2023cites this paper
• Bisphosphonates and Their Connection to Dental Procedures: Exploring Bisphosphonate-Related Osteonecrosis of the Jaws

  2023cites this paper
• Pathophysiology of Medication‐Related Osteonecrosis of the Jaw—A Minireview

  2023cites this paper
• Risk of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents - A retrospective study of 240 patients.

  2023cites this paper
• Rodents as an animal model for studying tooth extraction-related medication-related osteonecrosis of the jaw: assessment of outcomes.

  2023cites this paper
• MRONJ of the Mandible—From Decortication to a Complex Jaw Reconstruction Using a CAD/CAM-Guided Bilateral Scapula Flap

  2023cites this paper
• A real‐world study on the prevalence and risk factors of medication related osteonecrosis of the jaw in cancer patients with bone metastases treated with Denosumab

  2023cites this paper
• Incidence and trend of antiresorptive agent-related osteonecrosis of the jaw from 2016 to 2020 in Kure, Japan

  2023cites this paper
• Bisphosphonates and Dental Implants: A Systematic Review and Meta-Analysis

  2023cites this paper
• Osteonecrosis of the Jaw

  2023cites this paper
• Preventive effect of teriparatide on medication-related osteonecrosis of the jaw in rats

  2023cites this paper
• The Use of Hydroxyapatite Loaded with Doxycycline (HADOX) in Dentoalveolar Surgery as a Risk-Reduction Therapeutic Protocol in Subjects Treated with Different Bisphosphonate Dosages

  2022cites this paper
• Infections in cancer patients with medication-related osteonecrosis of the jaws

  2022cites this paper
• The Effect of Eggshell and Seashell Nanoparticles Alone and Combined With Nd: YAG Laser on Occlusion and Remineralization Potential of Patent Dentinal Tubules: An In Vitro Study.

  2022cites this paper
• Indigenous microbiota protects development of medication-related osteonecrosis induced by periapical disease in mice

  2022cites this paper
• The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienists

  2022cites this paper
• Medication-Related Osteonecrosis of the Jaw – 2022 Update

  2022cites this paper
• Interventions for managing medication-related osteonecrosis of the jaw.

  2022cites this paper
• Medication-related osteonecrosis of the jaw: An update

  2022cites this paper
• Patients' Awareness of the Complications of Bisphosphonate Therapy

  2022cites this paper
• Radiographic predictors for MRONJ in oncologic patients undergoing tooth extraction

  2022cites this paper
• Dental Awareness and Barriers in Reducing the Risk of Medication-related Osteonecrosis of the Jaw (MRONJ) Among Non-head and Neck Cancer Patients

  2022cites this paper
• Nonexposed antiresorptive agent-related osteomyelitis of the jaw: a single-center cohort study

  2022cites this paper
• American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaw-2022 Update.

  2022cites this paper
• Medication-Related Osteonecrosis of the Jaw: A Critical Narrative Review

  2021cites this paper
• Effects of Osteoporosis Drugs: Morphological Assessment and Adverse Events

  2021cites this paper
• Promising results of surgical management of advanced medication related osteonecrosis of the jaws using adjunctive leukocyte and platelet rich fibrin

  2021cites this paper
• Diagnostic accuracy comparing OPT and CBCT in the detection of non-vital bone changes before tooth extractions in patients with antiresorptive intake.

  2021cites this paper
• OSTEONECROSIS OF THE JAW (ONJ) IN PROSTATE CANCER PATIENTS: EFFECT OF PREVENTIVE MEASURES IN A MONOINSTITUTIONAL EXPERIENCE

  2021cites this paper
• A retrospective study on the incidence of medication-related osteonecrosis of the jaws (MRONJ) associated with different preventive dental care modalities

  2021cites this paper
• Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score–matched analysis

  2021cites this paper
• Medication Related Osteonecrosis of the Jaw: 2021 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons

  2021cites this paper
• Medication-Related Osteonecrosis of the Jaw, a Hidden Enemy. An Integrative Review

  2021cites this paper
• Therapy with bone-modifying agents in cancer patients: Efficacy versus adverse events in dental medicine

  2021cites this paper
• Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ)

  2021cites this paper
• Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates

  2021cites this paper
• Preclinical Models of Medication-related Osteonecrosis of the Jaw (MRONJ).

  2021cites this paper
• Oral risk factors associated with medication-related osteonecrosis of the jaw in patients with cancer

  2021cites this paper
• Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases

  2021cites this paper
• Dental pathologies in tumor patients with bone metastases or multiple myeloma scheduled for antiresorptive therapy.

  2021cites this paper
• Evaluation The Efficiency of Nano Seashell, Sodium Fluoride And A Commercially Available Toothpaste On Dentinal Tubules Occlusion After Acid Attack Using Scanning Electron Microscope: In vitro Study.

  2021cites this paper
• Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS

  2021cites this paper
• The impact of drug therapy on minor oral surgery procedures

  2021cites this paper
• OSTEONECROSIS OF THE JAW (ONJ) IN BREAST CANCER PATIENTS: EFFECT OF PREVENTIVE MEASURES IN A MONOINSTITUTIONAL EXPERIENCE

  2021cites this paper
• Bone Health Management After Hematopoietic Cell Transplantation: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.

  2020cites this paper
• Are We Ready to Use Teriparatide to Treat Medication-Related Osteonecrosis of the Jaw in Clinical Practice?

  2020cites this paper
• Bone targeted therapy and skeletal related events in the era of enzalutamide and abiraterone acetate for castration resistant prostate cancer with bone metastases

  2020cites this paper
• Complications of Dentoalveolar Surgery.

  2020cites this paper
• Therapeutic approach and management algorithms in medication-related osteonecrosis of the jaw (MONJ): recommendations of a multidisciplinary group of experts

  2020cites this paper
• Buformin suppresses osteosarcoma via targeting AMPK signaling pathway

  2020cites this paper
• Proposal for a preventive protocol for medication-related osteonecrosis of the jaw

  2020influential citation
• Awareness among patient at risk of developing Medication Related Osteonecrosis of the Jaw (MRONJ) – A primary prevention strategy

  2020cites this paper
• Multi-Level Vertebroplasty for 6 or More Painful Osteoporotic Vertebral Body Compression Fractures Performed in the Same Procedural Setting: A Safety and Efficacy Report in Cancer Patients

  2020cites this paper
• Alendronate or Zoledronic acid do not impair wound healing after tooth extraction in postmenopausal women with osteoporosis.

  2020cites this paper
• Non-Dental Drugs A Dentist Should Know: A Review

  2020cites this paper
• Lääkkeiden aiheuttamat haittavaikutukset suussa

  2020cites this paper
• Medication Related Osteonecrosis of the Jaws: Definition, Prevention, Treatment and Current Approaches

  2020cites this paper
• Indigenous Microbiota Protects against Inflammation-Induced Osteonecrosis

  2020cites this paper
• Influence of ridge preservation procedures on extraction socket healing under antiresorptive therapy: An experimental study in rabbits.

  2020cites this paper
• Korreliert die Prävalenz der bisphosphonatassoziierten Kiefernekrosen mit der Einnahmedauer der Bisphosphonate bei Tumor- und Osteoporosepatienten?

  2020cites this paper
• Bone Metastases: Mechanisms of the Metastatic Process, Imaging and Therapy.

  2020cites this paper
• Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for Bone Metastases in Patients With Cancer.

  2020cites this paper
• Tooth extraction in mice administered zoledronate increases inflammatory cytokine levels and promotes osteonecrosis of the jaw

  2020cites this paper
• Medication-related osteonecrosis and osteoradionecrosis of the jaws: Update and current management.

  2020cites this paper
• Teriparatide Promotes Bone Healing in Medication-Related Osteonecrosis of the Jaw: A Placebo-Controlled, Randomized Trial.

  2020cites this paper
• Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells

  2020cites this paper
• Medication-related osteonecrosis of the jaw (MRONJ): An update on the Memorial Sloan Kettering Cancer Center (MSKCC) experience and the role of Pre-medication Dental Evaluation in the prevention of MRONJ

  2020cites this paper
• Medication related osteonecrosis of the jaw: a qualitative study investigating the understanding and knowledge of local oncology clinical nurse specialists

  2020cites this paper
• Influence of induced infection in medication-related osteonecrosis of the jaw development after tooth extraction: A study in rats.

  2019cites this paper
• Benzylideneacetone Derivatives Inhibit Osteoclastogenesis and Activate Osteoblastogenesis Independently Based on Specific Structure-Activity Relationship.

  2019cites this paper
• The incidence and relative risk of adverse events in patients treated with bisphosphonate therapy for breast cancer: a systematic review and meta-analysis

  2019cites this paper
• Gingival fibroblasts and medication-related osteonecrosis of the jaw: Results by real-time and wound healing in vitro assays.

  2019cites this paper
• MORE Care: Narrowing the Rural Interprofessional Oral Health Care Gap

  2019cites this paper
• Medication-Related Osteonecrosis of the Jaws: Review

  2019cites this paper
• Systemic comorbidities are associated with medication-related osteonecrosis of the jaws: Case-control study.

  2019cites this paper
• Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline.

  2019cites this paper
• The use of crevicular fluid to assess markers of inflammation and angiogenesis, IL-17 and VEGF, in patients with solid tumors receiving zoledronic acid and/or bevacizumab

  2019cites this paper
• Prevalence in Rice Rats with Generalized Periodontitis

  2019cites this paper
• Medication related osteonecrosis of the jaw in osteoporotic vs oncologic patients-quantifying radiographic appearance and relationship to clinical findings.

  2019cites this paper
• Management of Medication-related Osteonecrosis of the Jaw (MRONJ) risk in patients due to commence anti-resorptive/anti-angiogenic drugs – how should pre-drug-treatment dental preventive care be organised?

  2019cites this paper
• Zoledronate treatment duration is linked to bisphosphonate‐related osteonecrosis of the jaw prevalence in rice rats with generalized periodontitis

  2019cites this paper